Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice

QJM: An International Journal of Medicine

Volumn 89, Issue 8, 1996, Pages 613-622

  Scott, R J ^b   Aitchison, W R C ^a   Barker, P R ^a   McLaren, G I ^a  

^a General Practice Units in Edinburgh   (United Kingdom)

^b The Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENERAL PRACTICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALAISE; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; NECK PAIN; ORAL DRUG ADMINISTRATION; PARESTHESIA; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; VERTIGO; VOMITING;

EID: 0029760512     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.8.613     Document Type: Article

References (14)

1. Beattie DT, Connor HE, Fensk W, Humphrey PPA. The pharmacology of sumatriptan. Rev Contemp Pharmacother 1994; 5:285-94.
2. Humphrey PPA, Fensk W. Mode of action of the antimigraine drug sumatriptan. Trends Pharmacol Sci 1991; 12:444-6.
3. Pilgrim AJ, Blakeborough P. The clinical efficacy of sumatriptan in the acute treatment of migraine. Rev Contemp Pharmacother 1994; 5:295-309.
4. Simmons VE, Blakeborough P. The safety profile of sumatriptan in the acute treatment of migraine. Rev Contemp Pharmacother 1994; 5:319-28.
5. Oral Sumatriptan Dose-defining Study Group. Sumatriptan - an oral dose-defining study. Eur Neurol 1991; 31:300-5.
6. Oral Sumatriptan Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 1991; 31:306-13.
7. Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol 1994; 24:138-44.
8. Ferrari MD, James MH, Bates D, Pilgrim A, Ashford E, Anderson BA, Nappi G. Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia 1994; 14:330-8.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl 7:19-28.
10. Machin D, Campbell MJ. Statistical tables for the design of clinical trials. Oxford, Blackwell Scientific, 1987.
11. Fowler PA, Lacey LF, Thomas M, Keene ON, Tanner RJN, Baber NS. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol 1991; 31:291-4.
12. Mathew NT. Drug-induced headache. Neurol Clin 1990; 8:903-12.
13. Mathew NT, Kurman R, Perez F. Drug-induced refractory headache - clinical features and management. Headache 1990; 30:634-8.
14. Tansey MJB, Pilgrim AJ, Martin PM. Long-term experience with sumatriptan in the treatment of migraine. Eur Neurol 1993; 33:310-15.